Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity

Abstract Background In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of gut microbiota and the causal associations are yet to be clarified....

Full description

Bibliographic Details
Main Authors: Baike Liu, Zheran Liu, Tianxiang Jiang, Xiangshuai Gu, Xiaonan Yin, Zhaolun Cai, Xiaoqiao Zou, Lei Dai, Bo Zhang
Format: Article
Language:English
Published: BMC 2024-03-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-024-01741-7
_version_ 1797259453496557568
author Baike Liu
Zheran Liu
Tianxiang Jiang
Xiangshuai Gu
Xiaonan Yin
Zhaolun Cai
Xiaoqiao Zou
Lei Dai
Bo Zhang
author_facet Baike Liu
Zheran Liu
Tianxiang Jiang
Xiangshuai Gu
Xiaonan Yin
Zhaolun Cai
Xiaoqiao Zou
Lei Dai
Bo Zhang
author_sort Baike Liu
collection DOAJ
description Abstract Background In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of gut microbiota and the causal associations are yet to be clarified. Methods To investigate this, we first conducted a univariable bi-directional two-sample Mendelian randomization (MR) analysis. Instrumental variables (IVs) for gut microbiota were retrieved from the MiBioGen consortium (18,340 participants). GWAS summary data for irAEs were gathered from an ICIs-treated cohort with 1,751 cancer patients. Various MR analysis methods, including inverse variance weighted (IVW), MR PRESSO, maximum likelihood (ML), weighted median, weighted mode, and cML–MA–BIC, were used. Furthermore, multivariable MR (MVMR) analysis was performed to account for possible influencing instrumental variables. Results Our analysis identified fourteen gut bacterial taxa that were causally associated with irAEs. Notably, Lachnospiraceae was strongly associated with an increased risk of both high-grade and all-grade irAEs, even after accounting for the effect of BMI in the MVMR analysis. Akkermansia, Verrucomicrobiaceae, and Anaerostipes were found to exert protective roles in high-grade irAEs. However, Ruminiclostridium6, Coprococcus3, Collinsella, and Eubacterium (fissicatena group) were associated with a higher risk of developing high-grade irAEs. RuminococcaceaeUCG004, and DefluviitaleaceaeUCG011 were protective against all-grade irAEs, whereas Porphyromonadaceae, Roseburia, Eubacterium (brachy group), and Peptococcus were associated with an increased risk of all-grade irAEs. Conclusions Our analysis highlights a strong causal association between Lachnospiraceae and irAEs, along with some other gut microbial taxa. These findings provide potential modifiable targets for managing irAEs and warrant further investigation.
first_indexed 2024-04-24T23:09:40Z
format Article
id doaj.art-c053d50499fb49ce80e7e80ed42de623
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-04-24T23:09:40Z
publishDate 2024-03-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-c053d50499fb49ce80e7e80ed42de6232024-03-17T12:19:41ZengBMCEuropean Journal of Medical Research2047-783X2024-03-0129111610.1186/s40001-024-01741-7Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicityBaike Liu0Zheran Liu1Tianxiang Jiang2Xiangshuai Gu3Xiaonan Yin4Zhaolun Cai5Xiaoqiao Zou6Lei Dai7Bo Zhang8Department of General Surgery, West China Hospital, Sichuan UniversityDepartment of Biotherapy and National Clinical Research Center for Geriatrics, Cancer Center, West China Hospital, Sichuan UniversityDepartment of General Surgery, West China Hospital, Sichuan UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for BiotherapyDepartment of General Surgery, West China Hospital, Sichuan UniversityDepartment of General Surgery, West China Hospital, Sichuan UniversityDepartment of General Surgery, West China Hospital, Sichuan UniversityState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for BiotherapyDepartment of General Surgery, West China Hospital, Sichuan UniversityAbstract Background In cancer patients receiving immune checkpoint inhibitors (ICIs), there is emerging evidence suggesting a correlation between gut microbiota and immune-related adverse events (irAEs). However, the exact roles of gut microbiota and the causal associations are yet to be clarified. Methods To investigate this, we first conducted a univariable bi-directional two-sample Mendelian randomization (MR) analysis. Instrumental variables (IVs) for gut microbiota were retrieved from the MiBioGen consortium (18,340 participants). GWAS summary data for irAEs were gathered from an ICIs-treated cohort with 1,751 cancer patients. Various MR analysis methods, including inverse variance weighted (IVW), MR PRESSO, maximum likelihood (ML), weighted median, weighted mode, and cML–MA–BIC, were used. Furthermore, multivariable MR (MVMR) analysis was performed to account for possible influencing instrumental variables. Results Our analysis identified fourteen gut bacterial taxa that were causally associated with irAEs. Notably, Lachnospiraceae was strongly associated with an increased risk of both high-grade and all-grade irAEs, even after accounting for the effect of BMI in the MVMR analysis. Akkermansia, Verrucomicrobiaceae, and Anaerostipes were found to exert protective roles in high-grade irAEs. However, Ruminiclostridium6, Coprococcus3, Collinsella, and Eubacterium (fissicatena group) were associated with a higher risk of developing high-grade irAEs. RuminococcaceaeUCG004, and DefluviitaleaceaeUCG011 were protective against all-grade irAEs, whereas Porphyromonadaceae, Roseburia, Eubacterium (brachy group), and Peptococcus were associated with an increased risk of all-grade irAEs. Conclusions Our analysis highlights a strong causal association between Lachnospiraceae and irAEs, along with some other gut microbial taxa. These findings provide potential modifiable targets for managing irAEs and warrant further investigation.https://doi.org/10.1186/s40001-024-01741-7Gut microbiotaImmunotherapy toxicityImmune-related adverse effectsirAEsLachnospiraceaeAkkermansia
spellingShingle Baike Liu
Zheran Liu
Tianxiang Jiang
Xiangshuai Gu
Xiaonan Yin
Zhaolun Cai
Xiaoqiao Zou
Lei Dai
Bo Zhang
Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
European Journal of Medical Research
Gut microbiota
Immunotherapy toxicity
Immune-related adverse effects
irAEs
Lachnospiraceae
Akkermansia
title Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
title_full Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
title_fullStr Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
title_full_unstemmed Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
title_short Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
title_sort univariable and multivariable mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
topic Gut microbiota
Immunotherapy toxicity
Immune-related adverse effects
irAEs
Lachnospiraceae
Akkermansia
url https://doi.org/10.1186/s40001-024-01741-7
work_keys_str_mv AT baikeliu univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT zheranliu univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT tianxiangjiang univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT xiangshuaigu univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT xiaonanyin univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT zhaoluncai univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT xiaoqiaozou univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT leidai univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity
AT bozhang univariableandmultivariablemendelianrandomizationstudyidentifiedthekeyroleofgutmicrobiotainimmunotherapeutictoxicity